Literature DB >> 8874492

Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors.

C E Stewart1, P Rotwein.   

Abstract

The insulin-like growth factors (IGFs), IGF-I and IGF-II, comprise a conserved pair of secreted proteins with diverse effects on growth, development, and metabolism. Insulin-like growth factor action is initiated upon binding to cell-surface receptors and is modulated through interactions with secreted IGF binding proteins (IGFBPs). The last decade has seen an explosion of new information about the physiological roles of the IGFs. In this review, we critically examine this information from biochemical, cell biological, and molecular genetic perspectives. We discuss the structures and functions of the two IGF receptors, outline the actions of the six IGFBPs, and summarize and interpret recent studies highlighting essential roles for components of the IGF system in the growth and development of the embryo and fetus, in tissue differentiation, in cell survival and proliferation, and in cancer. These results are discussed in the context of new opportunities for understanding the mechanisms of IGF action in multiple biological processes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8874492     DOI: 10.1152/physrev.1996.76.4.1005

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  140 in total

1.  Dual control of muscle cell survival by distinct growth factor-regulated signaling pathways.

Authors:  M A Lawlor; X Feng; D R Everding; K Sieger; C E Stewart; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.

Authors:  M A Lawlor; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia.

Authors:  Si Won Lee; Soo Yoon Lee; Sa Ra Lee; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

4.  Decreased expression of insulin-like growth factor binding protein-5 during N-(4-hydroxyphenyl)retinamide-induced neuronal differentiation of ARPE-19 human retinal pigment epithelial cells: regulation by CCAAT/enhancer-binding protein.

Authors:  William Samuel; R Krishnan Kutty; Camasamudram Vijayasarathy; Iranzu Pascual; Todd Duncan; T Michael Redmond
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

5.  GH overexpression causes muscle hypertrophy independent from local IGF-I in a zebrafish transgenic model.

Authors:  Rafael Y Kuradomi; Márcio A Figueiredo; Carlos F C Lanes; Carlos E da Rosa; Daniela V Almeida; Rodrigo Maggioni; Maeli D P Silva; Luis F Marins
Journal:  Transgenic Res       Date:  2010-07-17       Impact factor: 2.788

6.  IGFBP-3, a sensitive marker of physical training and overtraining.

Authors:  M Elloumi; N El Elj; M Zaouali; F Maso; E Filaire; Z Tabka; G Lac
Journal:  Br J Sports Med       Date:  2005-09       Impact factor: 13.800

7.  Apoptosis induced by SRC-family tyrosine kinase inhibitors in cultured rat cortical cells.

Authors:  Tsuneo Takadera; Mineki Fujibayashi; Yoshiki Koriyama; Satoru Kato
Journal:  Neurotox Res       Date:  2011-10-18       Impact factor: 3.911

8.  Influence of promoter region variants of insulin-like growth factor pathway genes on the strength-training response of muscle phenotypes in older adults.

Authors:  Brian D Hand; Matthew C Kostek; Robert E Ferrell; Matthew J Delmonico; Larry W Douglass; Stephen M Roth; James M Hagberg; Ben F Hurley
Journal:  J Appl Physiol (1985)       Date:  2007-08-30

9.  Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions.

Authors:  W Kalus; M Zweckstetter; C Renner; Y Sanchez; J Georgescu; M Grol; D Demuth; R Schumacher; C Dony; K Lang; T A Holak
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

10.  Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women.

Authors:  Adana A Llanos; Theodore M Brasky; Ramona G Dumitrescu; Catalin Marian; Kepher H Makambi; Bhaskar V S Kallakury; Scott L Spear; David J Perry; Rafael J Convit; Mary E Platek; Lucile L Adams-Campbell; Jo L Freudenheim; Peter G Shields
Journal:  Breast Cancer Res Treat       Date:  2013-03-02       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.